angiotensin ii has been researched along with Albuminuria in 176 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (3.41) | 18.7374 |
| 1990's | 36 (20.45) | 18.2507 |
| 2000's | 62 (35.23) | 29.6817 |
| 2010's | 66 (37.50) | 24.3611 |
| 2020's | 6 (3.41) | 2.80 |
| Authors | Studies |
|---|---|
| Boekell, KL; Brown, BJ; Schlondorff, JS; Stotter, BR; Talbot, BE | 1 |
| Clahsen-van Groningen, MC; Cruz-López, EO; Danser, AHJ; Domenig, O; Foster, D; Garrelds, IM; Kasper, A; Nioi, P; Poglitsch, M; Ren, L; Rooney, T; Uijl, E; van Veghel, R; Zlatev, I | 1 |
| Bode, M; Bülow, J; Diemer, JN; Ehnert, N; Herrnstadt, GR; Huber, TB; Lindenmeyer, MT; Luu, TV; Teigeler, T; Tomas, NM; Wenzel, UO; Wiech, T | 1 |
| Cross, E; Groener, M; Hassan, H; Inoue, K; Ishibe, S; Li, W; Mundel, P; Pedigo, CE; Shin, JW; Soda, K; Tian, X; Velazquez, H; Wang, Y; Wang, Z; Yamamoto, K | 1 |
| Cui, Y; Dong, C; Guo, Q; Liu, S | 1 |
| Chaves, FJ; Cortes, R; Martinez-Arroyo, O; Ortega, A; Perez-Hernandez, J; Redon, J | 1 |
| Birnbaumer, L; Chaudhari, S; Ding, Y; Li, W; Ma, R; Smedley, C; Wang, Y | 1 |
| Jang, HC; Kim, KM; Kong, SH; Lee, DH; Lee, JE; Lim, S; Min, SH; Oh, TJ; Park, KS | 1 |
| Cechova, S; Chan, F; Dong, F; Kelley, MJ; Le, TH; Ruiz, P | 1 |
| Alánová, P; Červenka, L; Falck, JR; Hammock, BD; Husková, Z; Hwang, SH; Imig, JD; Kikerlová, S; Kolář, F; Kompanowska-Jezierska, E; Kopkan, L; Neckář, J; Sadowski, J; Sedláková, L; Vaňourková, Z | 1 |
| Bu, X; Duan, X; He, Y; Hu, H; Liu, H; Ming, X; Sun, S; Wu, Q; Yan, F; Zhu, H | 1 |
| Hu, J; Li, N; Li, PL; Wang, W; Wang, Z; Yi, F; Zhu, Q | 1 |
| Ban, TH; Chang, YS; Choi, BS; Jang, IA; Kim, EN; Kim, MY; Lim, JH; Park, CW; Yoon, HE | 1 |
| Llinas, MT; Martinez, CM; Moreno, JM; Oltra, L; Reverte, V; Salazar, FJ; Tapia, A | 1 |
| Liu, Y; Ma, R; Song, L; Xu, Y; Yao, D; Zhang, D; Zhou, H | 1 |
| Fu, H; Hou, FF; Li, A; Liu, Y; Tan, RJ; Xiao, L; Xu, B; Zhou, D; Zhou, L | 1 |
| Arias, SCA; Ávila, VF; Camara, NOS; Faustino, VD; Foresto-Neto, O; Fujihara, CK; Malheiros, DMAC; Zatz, R | 1 |
| Ichikawa, H; Kimura, Y; Narita, I; Narita, M; Okumura, K; Osanai, T; Shimada, M; Tanaka, M; Tomita, H | 1 |
| Balogh, A; Bartolomaeus, H; Dechend, R; Forslund, SK; Henke, N; Klamer, S; Luft, FC; Markó, L; Müller, DN; Park, JK; Rong, S; Ruland, J; Wilck, N | 1 |
| Nistala, R; Whaley-Connell, A | 1 |
| Auger, C; Kang, M; Kim, KR; Lee, JO; Oak, MH; Park, DH; Schini-Kerth, VB | 1 |
| Dai, C; He, W; Jiang, L; Li, J; Mao, J; Song, Y; Xu, L; Yang, J; Zhao, AZ | 1 |
| Ayuzawa, N; Fujita, T; Ishizawa, K; Kawarazaki, W; Nagase, M; Takeuchi, M; Ueda, K; Yoshida, S | 1 |
| D'Angelo, A; Derosa, G; Fogari, R; Gualtierotti, R; Lazzari, P; Mugellini, A; Zoppi, A | 1 |
| Ichikawa, I; Matsusaka, T; Niimura, F; Nishiyama, A; Pastan, I; Shintani, A | 1 |
| Dechend, R; Haase, N; Müller, DN; Przybyl, L; Qadri, F; Rugor, J | 1 |
| Baum, M; Gattineni, J; Guzman, GL; Siddique, K | 1 |
| Entman, ML; Jin, X; Wang, Y; Xia, Y; Yan, J | 1 |
| Aisa, HA; Bakri, M; Chen, LD; Wang, MH; Yi, Y | 1 |
| Ekeloef, NP; Johansen, JK; Kancir, ASP; Pedersen, EB | 1 |
| Ichikawa, I; Matsusaka, T; Miyazaki, Y; Niimura, F; Nishiyama, A; Okabe, M; Pastan, I; Yokoo, T | 1 |
| Oliveira-Souza, M; Thieme, K | 1 |
| Chang, YH; Chen, JW; Chien, S; Chu, PH; Huang, PH; Li, SY; Lin, CC; Lin, SJ; Lin, TP; Schmid-Schönbein, GW; Tarng, DC; Yang, AH; Yang, MH; Yang, WC | 1 |
| Azegami, T; Hayashi, K; Itoh, H; Nakamura, M; Oguchi, H; Sakamaki, Y; Sasamura, H; Tokuyama, H; Wakino, S | 1 |
| Devarajan, S; Habe, S; Miura, S; Nishiyama, A; Saku, K; Uehara, Y; Urata, H; Yahiro, E | 1 |
| Ilatovskaya, DV; Levchenko, V; Lowing, A; Palygin, O; Shuyskiy, LS; Staruschenko, A | 1 |
| Baum, M; Elmaghrabi, A; Gattineni, J; Legan, SK; Mansuri, A | 1 |
| Diedrich, A; Finney, C; Harris, RC; Kloepfer, LA; Zeng, F | 1 |
| Ding, G; He, JC; Hu, C; Hua, H; Huang, S; Jia, Z; Rohatgi, R; Zhang, A; Zhang, X; Zhang, Y; Zhuang, Y | 1 |
| Červenka, L; Doleželová, Š; Falck, JR; Husková, Z; Imig, JD; Jíchová, Š; Kompanowska-Jezierska, E; Kopkan, L; Kramer, HJ; Kujal, P; Neckář, J; Reddy, RN; Sadowski, J; Vernerová, Z | 1 |
| Chen, J; Chen, M; Gu, J; He, L; Hu, H; Jing, Y; Li, L; Mei, C; Mei, S; Qi, N; Song, S; Sun, L; Wu, M; Wüthrich, RP; Yang, M | 1 |
| Batlle, D; David, NV; Fogo, A; Kanwar, Y; Khattab, AM; Martin, A; Osborn, M; Wysocki, J; Ye, M | 1 |
| Königshausen, E; Potthoff, SA; Quack, I; Ruetze, M; Rump, LC; Sellin, L; Stegbauer, J; Woznowski, M; Zierhut, UM | 1 |
| Bi, G; Cao, K; Fang, D; He, Y; Li, Z; Song, X; Wang, F; Wei, Y; Wu, J; Yang, J; Zhang, Z | 1 |
| Carretero, OA; Cavasin, MA; Kuziel, WA; Liao, TD; Liu, YH; Pagano, PJ; Shesely, EG; Yang, XP | 1 |
| Asselbergs, FW; Hillege, HL; van der Harst, P; van Gilst, WH; van Veldhuisen, DJ; Voors, AA | 1 |
| Hashimoto, K; Horino, T; Inoue, K; Iwasaki, Y; Kagawa, T; Matsumoto, R; Morita, T; Taguchi, T; Takao, T; Terada, Y | 1 |
| Hosomi, N; Imanishi, M; Ito, S; Kiyomoto, H; Kobori, H; Konishi, Y; Meda, I; Mori, T; Morikawa, T; Nagai, Y; Nakagawa, T; Nishiyama, A; Okada, N; Okumura, M | 1 |
| Bivona, BJ; Feng, Y; Harrison-Bernard, LM; Lazartigues, E; Park, S | 1 |
| Das, S; De Miguel, C; Mattson, DL; Rajapakse, NW | 1 |
| Gul, R; Jang, KY; Kim, SY; Kim, UH; Park, KH | 1 |
| Fiebeler, A; Haller, H; Luft, FC; Menne, J; Mervaala, EM; Muller, DN; Park, JK | 1 |
| Arbeeny, C; Chen, Y; Deb, DK; Kong, J; Li, G; Li, YC; Ning, G; Sabbagh, Y; Strugnell, S; Wang, Y; Zhang, Y; Zhang, Z | 1 |
| Ravid, M | 1 |
| Basu, R; Chow, FL; Herzenberg, AM; Janzek, E; Kassiri, Z; Liu, GC; Loibner, H; Oudit, GY; Penninger, JM; Scholey, JW; Schuster, M; Zhong, J; Zhou, J | 1 |
| Burchette, JL; Crowley, SD; Griffiths, R; Howell, DN; Lin, EE; Okeiyi, B; Ruiz, P; Song, YS; Sparks, M; Sprung, G; Stegbauer, J; Tharaux, PL; Yan, M; Yang, Y | 1 |
| Ferrario, CM; Habibi, J; Hayden, MR; Johnson, MS; Nistala, R; Rehmer, N; Schneider, RI; Sowers, JR; Tilmon, R; Whaley-Connell, A | 1 |
| Audoly, LP; Coffman, TM; Facemire, CS; Griffiths, R; Koller, BH | 1 |
| Collins, AR; Hsueh, WA; Kim, J; Liu, J; Nguyen, L; Nicholas, SB; Ren, Y | 1 |
| Burns, KD; Dilauro, M; Genest, D; Robertson, SJ; Zimpelmann, J | 1 |
| Cowley, AW; Jin, C; Polichnowski, AJ; Yang, C | 1 |
| Arakawa, K; Fujii, M; Inoki, I; Kimura, T; Konoshita, T; Makino, Y; Miyamori, I; Nakamura, H; Wakahara, S | 1 |
| Cervenka, L; Husková, Z; Kramer, HJ; Vaněčková, I; Vaňourková, Z | 1 |
| Fujii, M; Inoguchi, T; Kobayashi, K; Maeda, Y; Sasaki, S; Takayanagi, R; Zheng, J | 1 |
| Hara, T; Hitomi, H; Ihara, G; Ito, S; Kiyomoto, H; Kobori, H; Kohno, M; Mori, T; Nagai, Y; Nakano, D; Nishiyama, A; Ohashi, N; Pelisch, N | 1 |
| Chen, R; Eisner, C; Hu, X; Huang, Y; Kopp, JB; Leelahavanichkul, A; Mizel, D; Schnermann, J; Star, RA; Wright, EC; Yan, Q; Yuen, PS; Zhou, H | 1 |
| Barisoni, L; Birbaumer, L; Bowling, B; Burch, J; Byrd, A; Eckel, J; Finch, EA; Gbadegesin, R; Hall, G; Homstad, A; Lavin, PJ; Mukerji, N; Rosenberg, P; Sparks, M; Winn, MP; Wu, G; Zhang, ZS | 1 |
| Baylis, C; Molnar, M; Sasser, JM | 1 |
| Dong, YF; Kataoka, K; Kim-Mitsuyama, S; Koibuchi, N; Nakamura, T; Nako, H; Ogawa, H; Tokutomi, Y; Toyama, K; Yamamoto, E; Yasuda, O | 1 |
| Franke, S; Fraune, C; Krebs, C; Rüster, C; Schmidthaupt, R; Wenzel, U; Wolf, G | 1 |
| Coffman, TM; Crowley, SD; Griffiths, R; Herrera, M; Ruiz, P; Zhang, J | 1 |
| Abbate, A; Dhaduk, R; Li, N; Li, PL; Van Tassell, BW; Wang, Z; Xia, M; Zhu, Q | 1 |
| Graciano, ML; Mitchell, KD | 1 |
| Abe, H; Doi, T; Matsubara, T; Tominaga, T | 1 |
| Ahmed, SB; Hemmelgarn, BR; MacRae, JM; Muruve, DA; Nicholl, DD; Sola, DY; Turin, TC | 1 |
| Huang, XR; Lan, HY; Liu, Z | 1 |
| Fan, YY; Hitomi, H; Kitada, K; Kobori, H; Lei, B; Masaki, T; Mori, H; Nakano, D; Nishiyama, A | 1 |
| Kusumoto, K | 1 |
| Baucke, J; Danser, AH; Divac, N; Fraune, C; Frenay, AR; Garrelds, IM; Hölzel, A; Jankowski, V; Krebs, C; Lange, S; Nguyen, G; Schwedhelm, E; Stahl, R; Streichert, T; van Goor, H; Velden, J; Wenzel, UO | 1 |
| Cook, AK; Giddens, MI; Guan, Z; Hobbs, JL; Inscho, EW; Osmond, DA; Pollock, DM; Pollock, JS; Yamamoto, T; Zhang, S | 1 |
| Bodner, J; Connaire, J; Ericksen, J; Ibrahim, HN; Jackson, S; Kasiske, B; Lentsch, N; Matas, A; Mauer, M; Najafian, B; Ney, A; West, A | 1 |
| Fan, YY; Hitomi, H; Huang, W; Kobori, H; Li, P; Masaki, T; Mori, H; Nakano, D; Nishiyama, A; Sun, YX; Zhang, L; Zhi, N; Zhu, B | 1 |
| Fujita, T; Goto, A; Kobayashi, N; Matsuoka, H; Onozato, ML; Tojo, A | 1 |
| Hulthén, UL | 1 |
| Cheng, ZJ; Finckenberg, P; Louhelainen, M; Merasto, S; Mervaala, EM; Tikkanen, I; Vapaatalo, H | 1 |
| Cristol, JP; Delbosc, S; Jover, B; Mimran, A; Rugale, C | 1 |
| Clavant, SP; Comper, WD; Forbes, JM; Jerums, G; Osicka, TM; Thallas, V | 1 |
| Camussi, G; Deferrari, G; Doublier, S; Lupia, E; Ruotsalainen, V; Salvidio, G; Verzola, D | 1 |
| Blumenstein, M; Dietrich, W | 1 |
| Mohanram, A; Toto, RD | 1 |
| Dechend, R; Finckenberg, P; Ganten, D; Lapatto, R; Luft, FC; Mervaala, E; Müller, DN; Park, JK; Vapaatalo, H | 1 |
| Fujita, T; Goto, A; Kurihara, H; Onozato, ML; Sakai, T; Tojo, A | 1 |
| Bianchetti, MG; Edefonti, A; Fossali, E; Gartenmann, AC; Schmidtko, J; Simonetti, GD; von Vigier, RO | 1 |
| Kamper, AL; Karlsen, FM | 1 |
| Andersen, S; Bröchner-Mortensen, J; Parving, HH | 1 |
| Cantarovich, F; Rangoonwala, B | 1 |
| Athirakul, K; Coffman, TM; Francois, H; Mao, L; Rockman, H | 1 |
| Bramlage, P; Dikow, R; Kirch, W; Lehnert, H; Pittrow, D; Ritz, E; Wittchen, HU | 1 |
| Ruilope, LM; Segura, J | 1 |
| Awad, AS; Carey, RM; Siragy, HM; Webb, RL | 2 |
| Battegay, E; Zeller, A | 1 |
| Ohashi, H; Takagi, H | 1 |
| Braesen, JH; Dechend, R; Fiebeler, A; Gratze, P; Henke, N; Luft, FC; Muller, DN; Park, JK; Shagdarsuren, E; Wellner, M | 1 |
| Claverie, F; Flores, C; García, J; León, C; Milena, FJ; Mora, C; Navarro, JF | 1 |
| Cordaillat, M; Jover, B; Mimran, A; Rugale, C | 1 |
| Berge, RK; Gudbrandsen, OA; Hultstrøm, M; Iversen, BM; Leh, S; Monica Bivol, L; Vågnes, Ø | 1 |
| Rump, LC | 1 |
| Castells, MT; Loria, A; Reverte, V; Saez, F; Salazar, F; Salazar, FJ; Zuasti, A | 1 |
| Brenner, BM; Cooper, ME; de Zeeuw, D; Eijkelkamp, WB; Gleim, GW; Keane, WF; Parving, HH; Remuzzi, G; Shahinfar, S; Weir, MR; Zhang, Z | 1 |
| Dechend, R; Dietz, R; Gross, V; Henke, N; Luft, FC; Muller, DN; Obst, M; Park, JK; Qadri, F; Scheidereit, C; Schmidt-Ullrich, R; Wellner, M | 1 |
| Guzik, TJ; Harrison, DG | 1 |
| Boesen, EI; Pollock, DM; Pollock, JS; Semprun-Prieto, L; Sullivan, JC | 1 |
| Delbosc, S; Jover, B; Mimran, A; Rugale, C | 1 |
| Andresen, BT; Cooper, SA; DeMarco, VG; Ferrario, C; Habibi, J; Hayden, MR; Karuparthi, PR; Nistala, R; Rehmer, N; Sowers, JR; Wei, Y; Whaley-Connell, A | 1 |
| Dorsett-Martin, W; Iliescu, R; Reckelhoff, JF; Sartori-Valinotti, JC; Yanes, LL | 1 |
| Burchette, JL; Coffman, TM; Crowley, SD; Frey, CW; Gould, SK; Griffiths, R; Howell, DN; Kim, HS; Makhanova, N; Ruiz, P; Tharaux, PL; Yan, M | 1 |
| Feddergreen, W; Kashgarian, M; Stein, HD; Sterzel, RB | 1 |
| Fitzgibbon, WR; Hutchison, FN; Imamura, A; Lacy, ER; Mackenzie, HS; Ploth, DW | 1 |
| García Puig, J; Mateos Antón, F | 1 |
| Aldigier, JC; Baussant, T; Chassain, AP; Dalmay, F; Galen, FX; Huang, H; Lartigue, M; Leroux-Robert, C | 1 |
| Dawson, D; Denver, E; Foyle, WJ; Pinkney, J; Sampson, MJ; Yudkin, JS | 1 |
| Baboolal, K; Meyer, TW | 1 |
| Chatani, F; Hamaguchi, A; Inada, Y; Ishimura, Y; Kim, S; Miura, K; Ohta, K; Omura, T; Wada, T; Yukimura, T | 1 |
| de Jong, PE; de Zeeuw, D; Gansevoort, RT; Redfield, A; Shahinfar, S | 1 |
| Christensen, P; Feldt-Rasmussen, B; Jensen, T; Nørgaard, K | 1 |
| Cohen, N; Gilbert, R; Jerums, G; Phillips, P | 1 |
| Higaki, J; Kohara, K; Mikami, H; Ogihara, T; Okuda, N | 1 |
| Assad, N; Stahl, RA; Thaiss, F; Wolf, G; Zahner, G | 1 |
| Berra, N; Fauvel, JP; Laville, M; Madonna, O; Pozet, N; Velon, S; Zech, P | 1 |
| Assmann, KJ; de Jong, AS; Dijkman, HB; Koene, RA; Mentzel, S; van Son, JP; Wetzels, JF | 1 |
| Braun, N; Erley, CM; Furian, TC; Grau, C; Risler, T; Wolf, S | 1 |
| Adams-Huet, B; Fenves, AZ; Mitchell, HC; Mulcahy, W; Smith, RD; Toto, RD | 1 |
| Allen, TJ; Casley, D; Cooper, ME; Jerums, G; Waldron, MJ | 1 |
| Cipollina, MR; Di Virgilio, F; Duner, E; Nosadini, R; Trevisan, M; Trevisan, R | 1 |
| Cazes, M; Cloarec, A; García-Robles, R; Rábano, A; Ruilope, LM; Villa, E | 1 |
| Adèr, HJ; Donker, AJ; Gans, RO; Spooren, PF; Vermes, I | 1 |
| Baldoncini, R; Bellini, C; De Angelis, C; Desideri, G; Ferri, C; Santucci, A | 1 |
| Allen, TJ; Cao, Z; Cooper, ME; Hulthen, UL; Youssef, S | 1 |
| Hamaguchi, A; Iwao, H; Kim, S; Miura, K; Wanibuchi, H; Yamanaka, S | 1 |
| Bouriquet, N; Casellas, D; Herizi, A | 1 |
| Bech, JN; Hansen, HE; Jensen, KT; Kornerup, HJ; Nielsen, CB; Pedersen, EB; Spencer, ES; Sølling, J | 1 |
| Al-Bander, H; Hutchison, FN; Jones, H; Kaysen, GA; Webster, S | 1 |
| Brocco, S; Bruttomesso, D; Del Prato, S; Girardi, C; Jori, E; Mazzon, C; Pianta, A; Semplicini, A; Tiengo, A; Trevisan, R; Vedovato, M | 1 |
| Bünten, B; Grabensee, B; Németh, R; Plum, J | 1 |
| Herizi, A; Jover, B; Mimran, A; Pasquié, JL | 1 |
| Baldoncini, R; Bellini, C; De Mattia, G; Desideri, G; Ferri, C; Santucci, A; Valenti, M | 1 |
| Bieringer, M; Breu, V; Dechend, R; Fiebeler, A; Ganten, D; Haller, H; Luft, FC; Mervaala, E; Müller, DN; Park, JK; Schmidt, F | 1 |
| Bader, M; Breu, V; Ganten, D; Gross, V; Haller, H; Luft, FC; Mervaala, E; Müller, DN; Park, JK; Schmidt, F | 1 |
| Bancale, E; Cacace, G; Cesano, G; Gigliola, G; Mengozzi, G; Mosso, R; Paradisi, L; Picciotto, G; Piccoli, G; Polloni, R; Roccatello, D; Rossi, D; Sena, LM | 1 |
| Amann, K; Bielenberg, GW; Ehmke, H; Gross, ML; Koch, A; Mall, G; Oberhauser, V; Orth, SR; Ritz, E; Rump, LC; Simonaviciene, A; VAN Kats, JP; Wessels, S | 1 |
| Breu, V; Dechend, R; Ganten, D; Genersch, E; Haller, H; Löffler, BM; Luft, FC; Mervaala, EM; Muller, DN; Park, JK; Schmidt, F; Schneider, W | 1 |
| Guo, DF; Inagami, T; Kimura, H; Naito, A; Nakamura, T; Obata, J; Shimizu, F; Takano, H; Yoshida, Y | 1 |
| Bieringer, M; Dechend, R; Fiebeler, A; Ganten, D; Haller, H; Lindschau, C; Luft, FC; Mervaala, EM; Müller, DN; Park, JK; Schäfer, O; Schmidt, F; Schneider, W | 1 |
| Díez, J; Laviades, C; Varo, N | 1 |
| Raij, L | 1 |
| Allen, TJ; Bonnet, F; Cao, Z; Cooper, ME; Davis, B | 1 |
| El Khyat, Z; El Sayed, A; Ibrahim, S; Nicola, W; Salah, A; Sidhom, G | 1 |
| Andersen, S; Arner, P; Brøchner-Mortensen, J; Gomis, R; Lehnert, H; Parving, HH | 1 |
| Assmann, KJM; Danser, AHJ; Dieker, JWC; Dijkman, HBPM; Gerlofs-Nijland, ME; Groenen, PJTA; Mentzel, S; Smithies, O; van Kats, JP; van Son, JPHF; Wetzels, JFM | 1 |
| Allen, TJ; Baxter, AL; Casley, DJ; Cooper, ME; Houlihan, CA; Jerums, G; Panangiotopoulos, S | 1 |
| Arnqvist, HJ; Bojestig, M; Karlberg, BE; Ludvigsson, J; Nystrom, FH | 1 |
| Dilek, K; Ersoy, A; Güllülü, M; Oktay, B; Usta, M; Yavuz, M; Yurtkuran, M | 1 |
| Baylis, Ch; Bohrer, MP; Brenner, BM; Deen, WM | 1 |
| Eisenbach, GM; Van Liew, JB | 1 |
| Bagger, JP; Eiskjaer, H; Mogensen, CE; Pedersen, EB; Schmitz, A | 1 |
| Templeton, DM; Whiteside, C | 1 |
| Date, Y; Iwanari, O; Kitao, M; Miyako, J; Moriyama, M; Nakayama, S; Ryuhkoh, K; Yoshino, N | 1 |
| Meyer, TW; Miller, PL; Rennke, HG | 1 |
| Ben, GP; Carraro, A; Cipollina, MG; Duner, E; Fioretto, P; Giorato, C; Mollo, F; Morocutti, A; Sacerdoti, D; Sambataro, M | 1 |
| Brezis, M; Kaminski, N; Raz, E | 1 |
| Aurell, M; Björck, S; Bresäter, LE; Herlitz, H; Welin, L; Wikstrand, J | 1 |
| Craig, KJ; Frier, BM; Hepburn, DA; Patrick, AW; Swainson, CP; Thomson, I | 1 |
| Thompson, J; Whiteside, CI | 1 |
| Damkjaer Nielsen, M; Edsberg, B; Giese, J; Hommel, E; Mathiesen, E; Parving, HH | 1 |
15 review(s) available for angiotensin ii and Albuminuria
| Article | Year |
|---|---|
12-Lipoxygenase as a key pharmacological target in the pathogenesis of diabetic nephropathy.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Albuminuria; Angiotensin II; Animals; Arachidonate 12-Lipoxygenase; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Diabetic Nephropathies; Epigenesis, Genetic; Epoprostenol; Humans | 2020 |
Resistance to insulin and kidney disease in the cardiorenal metabolic syndrome; role for angiotensin II.
Topics: Albuminuria; Angiotensin II; Animals; Cardio-Renal Syndrome; Humans; Insulin Resistance; Kidney Glomerulus; Metabolic Syndrome; Signal Transduction | 2013 |
Dual blockade of the renin-angiotensin system in diabetic nephropathy.
Topics: Albuminuria; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Humans; Meta-Analysis as Topic; Renin-Angiotensin System | 2009 |
[BMP4-Smad1 signaling pathway in pathogenesis of diabetic nephropathy].
Topics: Albuminuria; Angiotensin II; Animals; Biomarkers; Bone Morphogenetic Protein 4; Diabetic Nephropathies; Humans; Signal Transduction; Smad1 Protein | 2011 |
[In vitro and in vivo pharmacological profiles of a novel angiotensin type 1-receptor blocker, azilsartan].
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Diabetes Mellitus, Type 2; Disease Models, Animal; Humans; Hypertension; Insulin Resistance; Obesity; Oxadiazoles | 2012 |
Nephrin: a pivotal molecule in proteinuria influenced by angiotensin II.
Topics: Albuminuria; Angiotensin II; Animals; Diabetic Angiopathies; Humans; Hypertension; Membrane Proteins; Proteins; Proteinuria | 2003 |
Outcome studies in diabetic nephropathy.
Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hyperglycemia; Hyperlipidemias; Hypertension, Renal; Irbesartan; Kidney Failure, Chronic; Male; Outcome Assessment, Health Care; Proteinuria; Renin-Angiotensin System; Risk Factors; Smoking; Tetrazoles | 2003 |
[Blockade of the renin-angiotensin system. ACE inhibitors, angiotensin II antagonists or both?].
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Heart Failure; Humans; Kidney Failure, Chronic; Myocardial Infarction; Proteinuria; Receptors, Angiotensin; Renin-Angiotensin System | 2003 |
Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clinical Trials as Topic; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Predictive Value of Tests; Renin-Angiotensin System; Risk Factors | 2003 |
Losartan and other angiotensin II antagonists for nephropathy in type 2 diabetes mellitus: a review of the clinical trial evidence.
Topics: Albuminuria; Amlodipine; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Irbesartan; Kidney Failure, Chronic; Losartan; Proteinuria; Tetrazoles | 2003 |
[Angiotensin II receptor blockers--evidence along the cardiovascular continuum].
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dogs; Drug Therapy, Combination; Female; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Placebos; Rabbits; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Stroke; Tetrazoles; Time Factors | 2005 |
[The Diabetic Retinopathy Candesartan Trials (DIRECT) programme].
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Diabetic Retinopathy; Humans; Hypertension; Randomized Controlled Trials as Topic; Receptors, Vascular Endothelial Growth Factor; Renin-Angiotensin System; Retina; Risk Factors; Tetrazoles; Vascular Endothelial Growth Factor A | 2005 |
Secondary rise of albuminuria under AT1-receptor blockade--what is the potential role of aldosterone escape?
Topics: Albuminuria; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Humans; Mineralocorticoid Receptor Antagonists; Models, Biological; Proteinuria | 2007 |
[The kidney in essential arterial hypertension: should microalbuminuria excretion be measured?].
Topics: Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Hemodynamics; Humans; Hypertension; Hypertension, Renal; Kidney; Rabbits; Risk Factors | 1995 |
Workshop: hypertension and cardiovascular risk factors: role of the angiotensin II-nitric oxide interaction.
Topics: Albuminuria; Angiotensin II; Animals; Cardiovascular Diseases; Diabetes Complications; Endothelium, Vascular; Homeostasis; Humans; Hypertension; Nitric Oxide; Nitric Oxide Synthase; Renin-Angiotensin System; Risk Factors; Superoxides | 2001 |
22 trial(s) available for angiotensin ii and Albuminuria
| Article | Year |
|---|---|
Effect of imidapril versus ramipril on urinary albumin excretion in hypertensive patients with type 2 diabetes and microalbuminuria.
Topics: Adult; Aged; Albumins; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Diabetes Mellitus, Type 2; Female; Humans; Hypertension; Imidazolidines; Male; Middle Aged; Natriuretic Peptide, Brain; Prospective Studies; Ramipril; Treatment Outcome | 2013 |
The effect of 6% hydroxyethyl starch 130/0.4 on renal function, arterial blood pressure, and vasoactive hormones during radical prostatectomy: a randomized controlled trial.
Topics: Acute-Phase Proteins; Aged; Albuminuria; Aldosterone; Angiotensin II; Arterial Pressure; Biomarkers; Blood Loss, Surgical; Creatinine; Denmark; Double-Blind Method; Fluid Therapy; Humans; Hydroxyethyl Starch Derivatives; Kidney; Lipocalin-2; Lipocalins; Male; Middle Aged; Plasma Substitutes; Prostatectomy; Proto-Oncogene Proteins; Renin; Renin-Angiotensin System; Time Factors; Treatment Outcome; Vasopressins | 2015 |
Effect of fosinopril treatment on serum C-reactive protein levels in patients with microalbuminuria.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; C-Reactive Protein; Double-Blind Method; Female; Fosinopril; Humans; Inflammation; Male; Middle Aged; Odds Ratio; Renin-Angiotensin System; Sex Factors | 2008 |
A new-generation N/L-type calcium channel blocker leads to less activation of the renin-angiotensin system compared with conventional L type calcium channel blocker.
Topics: Aged; Albuminuria; Aldosterone; Amlodipine; Angiotensin I; Angiotensin II; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Dihydropyridines; Dose-Response Relationship, Drug; Female; Humans; Hypertension; Male; Middle Aged; Renin; Renin-Angiotensin System | 2010 |
Angiotensin II blockade in kidney transplant recipients.
Topics: Adult; Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Double-Blind Method; Female; Fibrosis; Glomerular Filtration Rate; Humans; Kidney; Kidney Transplantation; Losartan; Male; Middle Aged; Postoperative Complications; Transplantation, Homologous; Treatment Outcome | 2013 |
Better renoprotective effect of angiotensin II antagonist compared to dihydropyridine calcium channel blocker in childhood.
Topics: Adolescent; Albuminuria; Amlodipine; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Calcium Channel Blockers; Child; Creatinine; Cytoprotection; Female; Humans; Hypertension; Irbesartan; Kidney; Male; Serum Albumin; Tetrazoles | 2003 |
Kidney function during and after withdrawal of long-term irbesartan treatment in patients with type 2 diabetes and microalbuminuria.
Topics: Albuminuria; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Humans; Irbesartan; Kidney Function Tests; Male; Middle Aged; Placebos; Tetrazoles | 2003 |
Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
Topics: Aged; Albuminuria; Angiotensin II; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Placebos | 2007 |
Angiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans.
Topics: Adult; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cyclic GMP; Double-Blind Method; Exercise; Exercise Test; Hemodynamics; Hormones; Humans; Male; Renin-Angiotensin System; Urodynamics | 1993 |
Effects of the angiotensin II antagonist losartan in hypertensive patients with renal disease.
Topics: Albuminuria; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Imidazoles; Longitudinal Studies; Losartan; Male; Proteinuria; Renal Circulation; Single-Blind Method; Tetrazoles; Uric Acid | 1994 |
A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension.
Topics: Adult; Albuminuria; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Enalapril; Endothelium, Vascular; Female; Humans; Hypertension; Isradipine; Lipoproteins; Male; Middle Aged; Potassium; Sodium | 1993 |
Effects of losartan on renal function in patients with essential hypertension.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Imidazoles; Kidney; Losartan; Male; Middle Aged; Renal Circulation; Single-Blind Method; Sodium; Tetrazoles; Uric Acid | 1996 |
Effect of ramipril on blood pressure and protein excretion rate in normotensive nondiabetic patients with proteinuria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Cross-Over Studies; Diabetes Mellitus; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Middle Aged; Prospective Studies; Proteinuria; Ramipril; Renal Plasma Flow | 1996 |
A comparison of the effect of ramipril, felodipine and placebo on glomerular filtration rate, albuminuria, blood pressure and vasoactive hormones in chronic glomerulonephritis. A randomized, prospective, double-blind, placebo-controlled study over two yea
Topics: Adolescent; Adult; Aged; Albuminuria; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Endothelins; Felodipine; Female; Glomerular Filtration Rate; Glomerulonephritis; Humans; Male; Middle Aged; Placebos; Prospective Studies; Ramipril | 1997 |
Effects of the angiotensin II antagonist valsartan on blood pressure, proteinuria, and renal hemodynamics in patients with chronic renal failure and hypertension.
Topics: Aged; Albuminuria; Angiotensin II; Antihypertensive Agents; Blood Pressure; Blood Urea Nitrogen; Creatinine; Dextrans; Double-Blind Method; Erythrocyte Count; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Inulin; Kidney Failure, Chronic; Kidney Glomerulus; Male; Middle Aged; Molecular Weight; p-Aminohippuric Acid; Particle Size; Potassium; Prospective Studies; Proteinuria; Renal Circulation; Tetrazoles; Valine; Valsartan | 1998 |
High plasma renin activity is combined with elevated urinary albumin excretion in essential hypertensive patients.
Topics: Adult; Aged; Albuminuria; Angiotensin II; Blood Pressure; Creatinine; Female; Humans; Hypertension; Male; Middle Aged; Multivariate Analysis; Renin; Renin-Angiotensin System; Sodium Chloride | 1999 |
Effects of angiotensin II blockade on nitric oxide blood levels in IgA nephropathy.
Topics: Adult; Aged; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Glomerulonephritis, IGA; Hemoglobins; Humans; Isosorbide Dinitrate; Losartan; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Reference Values; Renal Circulation | 2000 |
Transforming growth factor beta in hypertensives with cardiorenal damage.
Topics: Albuminuria; Angiotensin II; Antihypertensive Agents; Collagen; Collagen Type I; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Peptide Fragments; Peptides; Procollagen; Transforming Growth Factor beta; Transforming Growth Factor beta1; Treatment Outcome | 2000 |
[Effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes].
Topics: Adult; Aged; Albuminuria; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Double-Blind Method; Female; Follow-Up Studies; Humans; Irbesartan; Male; Middle Aged; Renin-Angiotensin System; Tetrazoles | 2001 |
A low-sodium diet potentiates the effects of losartan in type 2 diabetes.
Topics: Albuminuria; Aldosterone; Angiotensin II; Antihypertensive Agents; Blood Glucose; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diet, Sodium-Restricted; Drug Synergism; Female; Hemodynamics; Humans; Losartan; Male; Middle Aged; Placebos; Renal Circulation; Renin; Sodium | 2002 |
Angiotensin-II receptor antagonist losartan reduces microalbuminuria in hypertensive renal transplant recipients.
Topics: Adolescent; Adult; Albuminuria; Angiotensin II; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Kidney Transplantation; Losartan; Male; Middle Aged | 2002 |
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy.
Topics: Adult; Albuminuria; Angiotensin II; Blood Pressure; Captopril; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Middle Aged | 1986 |
139 other study(ies) available for angiotensin ii and Albuminuria
| Article | Year |
|---|---|
Gain-of-function, focal segmental glomerulosclerosis Trpc6 mutation minimally affects susceptibility to renal injury in several mouse models.
Topics: Albuminuria; Angiotensin II; Animals; Disease Models, Animal; Gain of Function Mutation; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Kidney Diseases; Mice; Mutation; Podocytes; TRPC6 Cation Channel | 2022 |
Blood pressure-independent renoprotective effects of small interference RNA targeting liver angiotensinogen in experimental diabetes.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Diabetes Mellitus, Experimental; Humans; Hypertension; Kidney Diseases; Liver; Rats; Renin; Renin-Angiotensin System; RNA, Small Interfering; Valsartan | 2023 |
Complement component C3 as a new target to lower albuminuria in hypertensive kidney disease.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Hypertension; Hypertension, Renal; Kidney; Mice; RNA, Small Interfering | 2023 |
Inhibition of Endocytosis of Clathrin-Mediated Angiotensin II Receptor Type 1 in Podocytes Augments Glomerular Injury.
Topics: Adaptor Proteins, Signal Transducing; Albuminuria; Angiotensin II; Animals; Calcium Signaling; Cells, Cultured; Clathrin-Coated Vesicles; Creatinine; Dynamin I; Dynamin II; Endocytosis; Glomerulonephritis; Hemodynamics; Kidney Glomerulus; Male; Mice; Mice, Knockout; Neuropeptides; Podocytes; Pseudopodia; rac1 GTP-Binding Protein; Receptor, Angiotensin, Type 1 | 2019 |
The Rab-Rabphilin system in injured human podocytes stressed by glucose overload and angiotensin II.
Topics: Adaptor Proteins, Signal Transducing; Albuminuria; Angiotensin II; Apoptosis; Glucose; Humans; Nerve Tissue Proteins; Podocytes; rab GTP-Binding Proteins; Vesicular Transport Proteins | 2020 |
Increased glomerular filtration rate and impaired contractile function of mesangial cells in TRPC6 knockout mice.
Topics: Albuminuria; Angiotensin II; Animals; Arterial Pressure; Calcium; Calcium Signaling; Glomerular Filtration Rate; Male; Mesangial Cells; Mice; Mice, Knockout; Rats; Sodium-Calcium Exchanger; TRPC6 Cation Channel; Vasoconstriction | 2017 |
Association of angiotensin-II levels with albuminuria in subjects with normal glucose metabolism, prediabetes, and type 2 diabetes mellitus.
Topics: Aged; Albuminuria; Angiotensin II; Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Early Diagnosis; Endothelium, Vascular; Female; Hospitals, University; Humans; Insulin Resistance; Male; Microvessels; Middle Aged; Outpatient Clinics, Hospital; Prediabetic State; Republic of Korea; Risk Factors; Up-Regulation; Vasculitis | 2017 |
Topics: Actins; Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cell Movement; Cells, Cultured; Disease Models, Animal; Genotype; Hypertension; Male; Mice; Mutation, Missense; Myosin Heavy Chains; Nephrectomy; Nonmuscle Myosin Type IIA; Podocytes; Primary Cell Culture; Renal Insufficiency, Chronic; Sodium Chloride, Dietary; Stress Fibers; Tetrazoles | 2018 |
Two pharmacological epoxyeicosatrienoic acid-enhancing therapies are effectively antihypertensive and reduce the severity of ischemic arrhythmias in rats with angiotensin II-dependent hypertension.
Topics: Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Arachidonic Acids; Arrhythmias, Cardiac; Blood Pressure; Hypertension; Rats; Rats, Sprague-Dawley; Rats, Transgenic | 2018 |
Qiliqiangxin Protects against Renal Injury in Rat with Cardiorenal Syndrome Type I through Regulating the Inflammatory and Oxidative Stress Signaling.
Topics: Albuminuria; Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Cardio-Renal Syndrome; Creatinine; Cystatin C; Drugs, Chinese Herbal; Interleukin-6; Kidney; Male; Myocardial Infarction; NADPH Oxidase 2; Natriuretic Peptide, Brain; Oxidative Stress; Phytotherapy; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Reactive Oxygen Species; Receptor, Angiotensin, Type 1; Signal Transduction; Tumor Necrosis Factor-alpha | 2018 |
Downregulation of microRNA-429 contributes to angiotensin II-induced profibrotic effect in rat kidney.
Topics: Actins; Albuminuria; Angiotensin II; Animals; Cadherins; Calcium-Binding Proteins; Cell Line; Cell Transdifferentiation; Collagen; Down-Regulation; Epithelial-Mesenchymal Transition; Fibrosis; Kidney Tubules, Proximal; Male; MicroRNAs; Podocytes; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Effects of Resveratrol on the Renin-Angiotensin System in the Aging Kidney.
Topics: Albuminuria; Angiotensin I; Angiotensin II; Animals; Anti-Inflammatory Agents; Antioxidants; Collagen Type IV; Fibronectins; Fibrosis; Kidney; Male; Mice, Inbred C57BL; NADPH Oxidases; Nitric Oxide Synthase Type III; Oxidative Stress; Peptide Fragments; Plant Extracts; Proto-Oncogene Proteins; Receptors, Angiotensin; Receptors, G-Protein-Coupled; Renal Insufficiency, Chronic; Renin-Angiotensin System; Resveratrol; Superoxide Dismutase | 2018 |
Sex-dependent differences in the adverse renal changes induced by an early in life exposure to a high-fat diet.
Topics: Abdominal Fat; Adipokines; Adiposity; Age Factors; Albuminuria; Angiotensin II; Animals; Arterial Pressure; Diet, High-Fat; Disease Progression; Female; Hypertension; Inflammation Mediators; Kidney; Kidney Diseases; Male; Obesity; Rats, Sprague-Dawley; Sex Factors; Time Factors | 2019 |
Participation of the AngII/TRPC6/NFAT axis in the pathogenesis of podocyte injury in rats with type 2 diabetes.
Topics: Albuminuria; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Gene Expression Regulation; Glomerulosclerosis, Focal Segmental; Glucose; Humans; Kidney Glomerulus; NFATC Transcription Factors; Podocytes; Rats; TRPC6 Cation Channel | 2019 |
Wnt/β-catenin regulates blood pressure and kidney injury in rats.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; beta Catenin; Blood Pressure; Blood Urea Nitrogen; Bridged Bicyclo Compounds, Heterocyclic; Collagen Type I; Creatinine; Cyclic AMP Response Element-Binding Protein; Disease Models, Animal; Fibronectins; Gene Expression Regulation; Hypertension; Kidney; Male; Nephrectomy; Peptidyl-Dipeptidase A; Plasminogen Activator Inhibitor 1; Pyrimidinones; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Wnt Proteins; Wnt Signaling Pathway | 2019 |
Pathogenic role of angiotensin II and the NF-κB system in a model of malignant hypertensive nephrosclerosis.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Arterioles; Female; Glomerulosclerosis, Focal Segmental; Hypertension, Renal; Kidney Cortex; Kidney Glomerulus; Lactation; Losartan; Male; Nephrectomy; Nephritis; Nephrosclerosis; NF-kappa B; Pyrrolidines; Rats; Rats, Wistar; Thiocarbamates | 2019 |
Rivaroxaban, a Direct Factor Xa Inhibitor, Ameliorates Hypertensive Renal Damage Through Inhibition of the Inflammatory Response Mediated by Protease-Activated Receptor Pathway.
Topics: Albuminuria; Angiotensin II; Animals; Blood Coagulation; Factor Xa Inhibitors; Gene Knockdown Techniques; Glomerular Basement Membrane; Glomerular Mesangium; Humans; Hypertension; In Vitro Techniques; Inflammation; Kidney Glomerulus; Male; Mice; Mice, Transgenic; Podocytes; Receptor, PAR-2; Renal Insufficiency, Chronic; Renin; Reverse Transcriptase Polymerase Chain Reaction; Rivaroxaban; Vasoconstrictor Agents | 2019 |
B-cell lymphoma/leukaemia 10 and angiotensin II-induced kidney injury.
Topics: Acute Kidney Injury; Albuminuria; Angiotensin II; Animals; B-Cell CLL-Lymphoma 10 Protein; Cell Movement; Disease Models, Animal; Fibrosis; Hepatitis A Virus Cellular Receptor 1; Kidney; Kidney Transplantation; Lipocalin-2; Macrophages; Membrane Proteins; Mice, Inbred C57BL; Mice, Knockout; Podocytes; T-Lymphocyte Subsets; Time Factors | 2020 |
An ethanolic extract of Lindera obtusiloba stems, YJP-14, improves endothelial dysfunction, metabolic parameters and physical performance in diabetic db/db mice.
Topics: Albuminuria; Angiotensin II; Animals; Aorta; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Endothelium, Vascular; Ethanol; Exercise Tolerance; Gene Expression; Humans; Hyperglycemia; Hypoglycemic Agents; Lindera; Male; Mice; Mice, Transgenic; NADPH Oxidases; Nitric Oxide Synthase Type III; Pioglitazone; Plant Extracts; Prostaglandin-Endoperoxide Synthases; Receptor, Angiotensin, Type 1; Thiazolidinediones | 2013 |
Calmodulin-dependent protein kinase II/cAMP response element-binding protein/Wnt/β-catenin signaling cascade regulates angiotensin II-induced podocyte injury and albuminuria.
Topics: Albuminuria; Angiotensin II; Animals; beta Catenin; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Line, Transformed; Cyclic AMP Response Element-Binding Protein; Female; Intercellular Signaling Peptides and Proteins; Kinetin; Male; Mice; Mice, Inbred BALB C; Phosphorylation; Podocytes; Protein Kinase Inhibitors; Wnt Signaling Pathway | 2013 |
Renin inhibition ameliorates renal damage through prominent suppression of both angiotensin I and II in human renin angiotensinogen transgenic mice with high salt loading.
Topics: Albuminuria; Amides; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antihypertensive Agents; Blood Pressure; Cytoprotection; Disease Models, Animal; Disease Progression; Down-Regulation; Fumarates; Humans; Hydralazine; Hypertension; Kidney; Kidney Diseases; Mice; Mice, Transgenic; Ramipril; Renin; Renin-Angiotensin System; Sodium Chloride, Dietary; Time Factors | 2014 |
Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Antibodies, Monoclonal; Disease Models, Animal; Exotoxins; Genotype; Kidney Diseases; Kidney Tubules, Proximal; Liver; Membrane Proteins; Mice, Knockout; Phenotype; Podocytes; RNA, Messenger; Sodium; Time Factors; Up-Regulation | 2014 |
Relaxin does not improve Angiotensin II-induced target-organ damage.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Humans; Hypertension; Male; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Recombinant Proteins; Relaxin; Renin | 2014 |
Effect of postnatal maternal protein intake on prenatal programming of hypertension.
Topics: Albuminuria; Angiotensin II; Animal Nutritional Physiological Phenomena; Animals; Blood Pressure; Diet, Protein-Restricted; Dietary Proteins; Female; Hypertension; Kidney Glomerulus; Lactation; Maternal Nutritional Physiological Phenomena; Pregnancy; Prenatal Exposure Delayed Effects; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Solute Carrier Family 12, Member 1; Time Factors | 2014 |
CXCR6 plays a critical role in angiotensin II-induced renal injury and fibrosis.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Bone Marrow Transplantation; Cytokines; Disease Models, Animal; Fibrosis; Green Fluorescent Proteins; Hypertension; Inflammation Mediators; Kidney; Kidney Diseases; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myofibroblasts; Receptors, CXCR; Receptors, CXCR6; Signal Transduction; T-Lymphocytes; Time Factors | 2014 |
Alkaloids of Nitraria sibirica Pall. decrease hypertension and albuminuria in angiotensin II-salt hypertension.
Topics: Albuminuria; Alkaloids; Angiotensin II; Animals; Blood Pressure; Chemokine CCL2; Drugs, Chinese Herbal; Humans; Hypertension; Magnoliopsida; Male; Mice; Rats, Sprague-Dawley; Sodium Chloride, Dietary | 2014 |
Unilateral ureteral obstruction attenuates intrarenal angiotensin II generation induced by podocyte injury.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Antibodies, Monoclonal; Disease Models, Animal; Down-Regulation; Exotoxins; Female; Glomerular Filtration Rate; Humans; Interleukin-2 Receptor alpha Subunit; Kidney Diseases; Mice, Inbred C57BL; Mice, Transgenic; Podocytes; Renin-Angiotensin System; RNA, Messenger; Signal Transduction; Time Factors; Ureteral Obstruction | 2015 |
Renal hemodynamic and morphological changes after 7 and 28 days of leptin treatment: the participation of angiotensin II via the AT1 receptor.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Feeding Behavior; Hemodynamics; Immunohistochemistry; Kidney; Kidney Tubules; Leptin; Male; Peptides; Polymerase Chain Reaction; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Systole; Time Factors; Weight Gain | 2015 |
Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
Topics: Albuminuria; Angiotensin II; Animals; Cell Dedifferentiation; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Knockout Techniques; Glomerular Basement Membrane; Glucose; Humans; LIM-Homeodomain Proteins; Male; Mice; Muscle Proteins; Podocytes; Protein Transport; Transcription Factors; Transforming Growth Factor beta1; Wnt Signaling Pathway | 2015 |
Renin-angiotensin blockade resets podocyte epigenome through Kruppel-like Factor 4 and attenuates proteinuria.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cell Line; Disease Models, Animal; DNA Methylation; Dose-Response Relationship, Drug; Doxorubicin; Epigenesis, Genetic; Irbesartan; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Male; Membrane Proteins; Mice, Inbred C57BL; Mice, Knockout; Podocytes; Promoter Regions, Genetic; Renal Insufficiency, Chronic; Renin-Angiotensin System; Signal Transduction; Tetrazoles; Time Factors; Transfection | 2015 |
Depressor effect of chymase inhibitor in mice with high salt-induced moderate hypertension.
Topics: Albuminuria; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Chymases; Disease Models, Animal; Diuretics; Heart Rate; Hypertension; Male; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Renin-Angiotensin System; Serine Proteinase Inhibitors; Sodium Chloride, Dietary; Time Factors | 2015 |
Podocyte injury in diabetic nephropathy: implications of angiotensin II-dependent activation of TRPC channels.
Topics: Albuminuria; Angiotensin II; Animals; Calcium; Diabetic Nephropathies; Disease Models, Animal; Gene Expression; Podocytes; Rats; Rats, Inbred Dahl; TRPC Cation Channels | 2015 |
Transient Exposure of Enalapril Normalizes Prenatal Programming of Hypertension and Urinary Angiotensinogen Excretion.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Enalapril; Female; Hypertension; Kidney; Male; Pregnancy; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2015 |
Specific endothelial heparin-binding EGF-like growth factor deletion ameliorates renal injury induced by chronic angiotensin II infusion.
Topics: Albuminuria; Angiotensin II; Animals; Endothelium, Vascular; ErbB Receptors; Glomerulosclerosis, Focal Segmental; Heparin-binding EGF-like Growth Factor; Kidney; Mice; Mice, Knockout; Phosphorylation; Renal Insufficiency, Chronic | 2016 |
Albuminuria enhances NHE3 and NCC via stimulation of mitochondrial oxidative stress/angiotensin II axis.
Topics: Adolescent; Albuminuria; Angiotensin II; Animals; Child; Child, Preschool; Humans; Male; Mice; Mice, Inbred C57BL; Mitochondria; Oxidative Stress; Serum Albumin, Bovine; Sodium-Hydrogen Exchanger 3; Solute Carrier Family 12, Member 3 | 2016 |
Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.
Topics: 8,11,14-Eicosatrienoic Acid; Albuminuria; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Cytochrome P-450 CYP1A1; Hypertension, Malignant; Indoles; Kidney; Male; Peptide Fragments; Rats; Rats, Transgenic; Renin; Renin-Angiotensin System; Time Factors | 2016 |
Olmesartan Prevents Microalbuminuria in db/db Diabetic Mice Through Inhibition of Angiotensin II/p38/SIRT1-Induced Podocyte Apoptosis.
Topics: Albuminuria; Angiotensin II; Animals; Apoptosis; Cell Line; Diabetic Nephropathies; Disease Models, Animal; Imidazoles; Male; Mice; Mice, Inbred Strains; p38 Mitogen-Activated Protein Kinases; Podocytes; Sirtuin 1; Tetrazoles | 2016 |
Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy.
Topics: Albuminuria; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Autoantigens; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Kidney; Mice, Inbred C57BL; Mice, Knockout; Peptide Fragments; Peptidyl-Dipeptidase A; Recombinant Proteins; Time Factors | 2017 |
Angiotensin II increases glomerular permeability by β-arrestin mediated nephrin endocytosis.
Topics: Albuminuria; Angiotensin II; Animals; beta-Arrestins; Biotinylation; Blood Pressure; Cytoskeleton; Endocytosis; Female; GTP-Binding Proteins; HEK293 Cells; Humans; Kidney Glomerulus; Male; Membrane Proteins; Mice; Mutation; Permeability; Podocytes; Protein Binding; Signal Transduction; Type C Phospholipases | 2016 |
Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Down-Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Renal; Kidney; Male; Nephritis; NF-kappa B; Proteinuria; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Signal Transduction; Telmisartan; Transforming Growth Factor beta | 2017 |
Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension.
Topics: Albuminuria; Angiotensin II; Animals; Blotting, Western; Cell Movement; Cell Proliferation; Disease Models, Animal; Glomerular Filtration Rate; Hypertension; Immunohistochemistry; Inflammation; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nephrosclerosis; Probability; Random Allocation; Reactive Oxygen Species; Receptors, Chemokine; Reference Values; Sensitivity and Specificity | 2008 |
Effects of angiotensin II type 1 receptor blocker on albumin-induced cell damage in human renal proximal tubular epithelial cells.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylglucosaminidase; Albumins; Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cells, Cultured; Deoxyguanosine; Dose-Response Relationship, Drug; Humans; Imidazoles; Kidney Tubules, Proximal; NADPH Oxidases; Oxidative Stress; Tetrazoles; Valine; Valsartan | 2009 |
Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Collagen; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Hypertension, Renal; Kidney Cortex; Male; Podocytes; Rats; Rats, Inbred OLETF; RNA, Messenger; Telmisartan | 2008 |
Intact renal afferent arteriolar autoregulatory responsiveness in db/db mice.
Topics: Albuminuria; Angiotensin II; Animals; Arterioles; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucose; Heart Rate; Homeostasis; Male; Mannitol; Mice; Mice, Obese; Motor Activity; Receptors, Leptin; Renal Circulation; Renin-Angiotensin System; Telemetry | 2008 |
Exogenous L-arginine ameliorates angiotensin II-induced hypertension and renal damage in rats.
Topics: Albuminuria; Angiotensin II; Animals; Arginine; Blood Pressure; Consciousness; Creatinine; Drug Interactions; Glomerular Filtration Rate; Hypertension, Renal; Kidney Glomerulus; Male; Nitrates; Nitric Oxide; Nitrites; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 2008 |
Role of kidney ADP-ribosyl cyclase in diabetic nephropathy.
Topics: ADP-ribosyl Cyclase; Albuminuria; Angiotensin II; Animals; Azo Compounds; Cell Nucleus; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Matrix Proteins; Kidney; Male; Mice; Mice, Inbred C57BL; NFATC Transcription Factors; Phosphorylation; Proto-Oncogene Proteins c-akt | 2009 |
Rosuvastatin protects against angiotensin II-induced renal injury in a dose-dependent fashion.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Collagen Type IV; Disease Models, Animal; Dose-Response Relationship, Drug; Fibronectins; Fluorescent Antibody Technique, Indirect; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Immunohistochemistry; Inflammation; Intercellular Adhesion Molecule-1; Kidney; Kidney Cortex; Kidney Medulla; Male; Monocytes; Necrosis; Neutrophil Infiltration; Nitric Oxide Synthase Type II; Pyrimidines; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Rosuvastatin Calcium; Sulfonamides | 2009 |
Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Ergocalciferols; Fibrosis; Glomerular Basement Membrane; Inflammation Mediators; Losartan; Macrophages; Mice; Mice, Inbred DBA; Podocytes; Renin; Renin-Angiotensin System; Time Factors; Vitamins | 2009 |
Human recombinant ACE2 reduces the progression of diabetic nephropathy.
Topics: Actins; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Blood Coagulation; Blood Glucose; Blood Pressure; Collagen; Diabetic Nephropathies; Disease Progression; Heparin; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Peptidyl-Dipeptidase A; Recombinant Proteins; RNA, Messenger | 2010 |
A role for angiotensin II type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin II-dependent hypertension.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Bone Marrow Cells; Bone Marrow Transplantation; Cell Movement; Chemokine CCL2; Female; Gene Expression; Hypertension; Kidney; Lymphocytes; Macrophages; Male; Mice; Mice, Inbred Strains; Mice, Knockout; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; Transplantation Chimera | 2010 |
Comparative effect of direct renin inhibition and AT1R blockade on glomerular filtration barrier injury in the transgenic Ren2 rat.
Topics: Albuminuria; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Pressure; Fumarates; Glomerular Filtration Rate; Hypertension; Irbesartan; Kidney; Membrane Glycoproteins; Membrane Proteins; NADPH Oxidase 2; NADPH Oxidases; Oxidative Stress; Podocytes; Rats; Rats, Sprague-Dawley; Rats, Transgenic; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System; Tetrazoles; Tyrosine | 2010 |
The impact of microsomal prostaglandin e synthase 1 on blood pressure is determined by genetic background.
Topics: Albuminuria; Analysis of Variance; Angiotensin II; Animals; Blood Pressure; Dinoprostone; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Hypertension; Intramolecular Oxidoreductases; Kidney; Mice; Mice, Inbred DBA; Mice, Knockout; Microsomes; Probability; Prostaglandin-E Synthases; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2010 |
Critical role for osteopontin in diabetic nephropathy.
Topics: Albuminuria; Angiotensin II; Animals; Cells, Cultured; Collagen Type IV; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Hypoglycemic Agents; Insulin; Kidney Glomerulus; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteopontin; PPAR gamma; Thiazolidinediones; Transforming Growth Factor beta | 2010 |
Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease.
Topics: Albuminuria; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Chronic Disease; Disease Models, Animal; Glomerular Filtration Rate; Hematocrit; Imidazoles; Infusion Pumps; Injections, Subcutaneous; Inulin; Kidney; Kidney Diseases; Leucine; Losartan; Male; Mice; Nephrectomy; Organ Size; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptor, Angiotensin, Type 1; Receptors, G-Protein-Coupled; Time Factors | 2010 |
Role of renal perfusion pressure versus angiotensin II on renal oxidative stress in angiotensin II-induced hypertensive rats.
Topics: Albuminuria; Analysis of Variance; Angiotensin II; Animals; Blood Pressure; Disease Models, Animal; Hypertension, Renal; Infusions, Intravenous; Kidney Cortex; Kidney Function Tests; Kidney Medulla; Linear Models; Male; Malondialdehyde; Oxidative Stress; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Renal Circulation; Superoxides; Urinalysis; Vasoconstrictor Agents | 2010 |
Despite similar reduction of blood pressure and renal ANG II and ET-1 levels aliskiren but not losartan normalizes albuminuria in hypertensive Ren-2 rats.
Topics: Albuminuria; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Down-Regulation; Endothelin-1; Enzyme-Linked Immunosorbent Assay; Fumarates; Hypertension; Kidney; Losartan; Male; Mice; Pilot Projects; Radioimmunoassay; Rats; Rats, Transgenic; Renin; Time Factors | 2010 |
Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase.
Topics: Albuminuria; Angiotensin II; Animals; Antioxidants; Bilirubin; Biliverdine; Blood Glucose; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Down-Regulation; Endothelial Cells; Glomerular Mesangium; Glucose; Humans; Hyperbilirubinemia, Hereditary; Male; Mice; Mice, Inbred C57BL; NADPH Oxidase 4; NADPH Oxidases; Oxidative Stress; Rats; Rats, Gunn; Superoxides; Time Factors; Transforming Growth Factor beta1 | 2010 |
Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade.
Topics: Albuminuria; Angiotensin II; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Kidney; Kidney Glomerulus; Male; Podocytes; Rats; Rats, Long-Evans; Remission Induction; Sclerosis; Treatment Outcome | 2010 |
Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model.
Topics: Albuminuria; Anemia; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Chronic Disease; Desoxycorticosterone; Disease Models, Animal; Disease Progression; Fibrosis; Genetic Predisposition to Disease; Glomerulonephritis; Heart Diseases; Hydralazine; Hypertension; Imidazoles; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney; Kidney Diseases; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Nephrectomy; Sodium Chloride, Dietary; Species Specificity; Telemetry; Tetrazoles; Time Factors; X-Ray Microtomography | 2010 |
TRPC6 enhances angiotensin II-induced albuminuria.
Topics: Albuminuria; Angiotensin II; Animals; Calcium; Disease Models, Animal; Hypertension; Injections, Subcutaneous; Kidney; Male; Mice; Mice, Knockout; Patch-Clamp Techniques; Podocytes; TRPC Cation Channels; TRPC6 Cation Channel | 2011 |
Relaxin ameliorates hypertension and increases nitric oxide metabolite excretion in angiotensin II but not N(ω)-nitro-L-arginine methyl ester hypertensive rats.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Relaxin | 2011 |
Novel mechanism of salt-induced glomerular injury: critical role of eNOS and angiotensin II.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Biphenyl Compounds; Blood Pressure; Cyclic N-Oxides; Disease Models, Animal; Glomerulonephritis; Irbesartan; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Sodium Chloride, Dietary; Spin Labels; Tetrazoles | 2011 |
Podocytes of AT2 receptor knockout mice are protected from angiotensin II-mediated RAGE induction.
Topics: Albuminuria; Angiotensin II; Animals; Apoptosis; Blood Pressure; Crosses, Genetic; Diabetic Nephropathies; Immunohistochemistry; Kidney Glomerulus; Male; Mice; Mice, Inbred C57BL; Podocytes; Receptor for Advanced Glycation End Products; Receptors, Angiotensin; Receptors, Immunologic | 2011 |
Role of AT₁ receptor-mediated salt retention in angiotensin II-dependent hypertension.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Diet, Sodium-Restricted; Disease Progression; Hypertension, Renal; Kidney; Kidney Transplantation; Male; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Receptor, Angiotensin, Type 1; Salts | 2011 |
Silencing of hypoxia-inducible factor-1α gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Chronic Disease; Creatinine; Disease Models, Animal; Gene Expression Regulation; Gene Silencing; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney Diseases; Kidney Glomerulus; Male; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Vascular Endothelial Growth Factor A | 2011 |
Imatinib ameliorates renal morphological changes in Cyp1a1-Ren2 transgenic rats with inducible ANG II-dependent malignant hypertension.
Topics: Albuminuria; Angiotensin II; Animals; Benzamides; Cytochrome P-450 CYP1A1; Hypertension, Malignant; Imatinib Mesylate; Indoles; Kidney; Male; Piperazines; Pyrimidines; Rats; Rats, Transgenic; Receptors, Platelet-Derived Growth Factor; Renin | 2012 |
Increased urinary protein excretion in the "normal" range is associated with increased renin-angiotensin system activity.
Topics: Adult; Albuminuria; Angiotensin II; Blood Pressure; Female; Hemodynamics; Humans; Male; Middle Aged; Proteinuria; Renin-Angiotensin System; Vascular Resistance | 2012 |
Smad3 mediates ANG II-induced hypertensive kidney disease in mice.
Topics: Actins; Albuminuria; Angiotensin II; Animals; Chemokine CCL2; Collagen Type I; Collagen Type IV; Creatinine; Female; Fibronectins; Fibrosis; Hypertension; Kidney Diseases; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NF-kappa B; Smad3 Protein; Smad7 Protein; Transforming Growth Factor beta; Ubiquitin-Protein Ligases | 2012 |
Add-on aliskiren elicits stronger renoprotection than high-dose valsartan in type 2 diabetic KKAy mice that do not respond to low-dose valsartan.
Topics: Albuminuria; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Fumarates; Kidney; Male; Mice; Mice, Inbred C57BL; Renin; RNA, Messenger; Tetrazoles; Valine; Valsartan | 2012 |
AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
Topics: Albuminuria; Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Pressure; Dose-Response Relationship, Drug; Fumarates; Gene Expression; Kidney; Losartan; Male; Mice; Renal Insufficiency, Chronic; Renin; Renin-Angiotensin System; Treatment Outcome | 2012 |
Immunosuppression preserves renal autoregulatory function and microvascular P2X(1) receptor reactivity in ANG II-hypertensive rats.
Topics: Adenosine Triphosphate; Albuminuria; Angiotensin II; Animals; Arterioles; Homeostasis; Hypertension; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocyte Activation; Lymphocytes; Macrophages; Male; Mycophenolic Acid; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2X1; Renal Circulation; Transforming Growth Factor beta1 | 2013 |
Aberrant activation of the intrarenal renin-angiotensin system in the developing kidneys of type 2 diabetic rats.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Blood Glucose; Blood Pressure; Body Weight; Collagen; Connective Tissue Growth Factor; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female; Gene Expression Regulation; Kidney; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Inbred OLETF; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Time Factors; Transforming Growth Factor beta | 2013 |
Angiotensin II and oxidative stress in Dahl Salt-sensitive rat with heart failure.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Disease Models, Animal; Gene Expression; Heart Failure; Heart Ventricles; Hydrogen Peroxide; Imidazoles; Imidazolidines; Kidney; Male; NADPH Oxidases; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphoproteins; Rats; Rats, Inbred Dahl; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger | 2002 |
Cardiovascular and renal effects of cyclooxygenase inhibition in transgenic rats harboring mouse renin-2 gene (TGR[mREN2]27).
Topics: Albuminuria; Angiotensin II; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiomegaly; Cardiovascular System; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Eating; Furans; Gene Expression Regulation, Enzymologic; Isoenzymes; Kidney; Losartan; Male; Membrane Proteins; Mice; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Sulindac; Urination | 2003 |
Sodium restriction prevents cardiac hypertrophy and oxidative stress in angiotensin II hypertension.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Hypertension, Renal; Myocardium; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Renal Circulation; Sodium, Dietary; Vasoconstrictor Agents | 2003 |
Reversible angiotensin II-mediated albuminuria in rat kidneys is dynamically associated with cytoskeletal organization.
Topics: Albuminuria; Angiotensin II; Animals; Blood Proteins; Cytoskeleton; Immunohistochemistry; Infusion Pumps; Kidney; Kidney Tubules; Kinetics; Male; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Tubulin | 2003 |
Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II.
Topics: Adult; Aged; Albuminuria; Angiotensin II; Biopsy; Blotting, Western; Cells, Cultured; Cytochalasin B; Cytoskeleton; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Fluorescent Antibody Technique, Indirect; Gene Expression; Glycated Serum Albumin; Glycation End Products, Advanced; Humans; Kidney; Male; Membrane Proteins; Microscopy, Fluorescence; Middle Aged; Nephrotic Syndrome; Proteins; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serum Albumin; Tissue Distribution | 2003 |
[Microalbuminuria as a warning sign of diabetic nephropathy. Test your diabetics early!].
Topics: Adolescent; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Benzothiadiazines; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Humans; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Kidney Failure, Chronic; Risk Factors; Smoking Cessation; Sodium Chloride Symporter Inhibitors; Time Factors | 2003 |
Lipoic acid supplementation prevents angiotensin II-induced renal injury.
Topics: Albuminuria; Angiotensin II; Animals; Animals, Genetically Modified; Antioxidants; Blood Pressure; Cardiomegaly; Cell Division; Glutathione; Homeostasis; Kidney; Leukocytes; Male; Myocardium; Nephritis; NF-kappa B; Oxidative Stress; Rats; Rats, Sprague-Dawley; Thioctic Acid; Transcription Factor AP-1; Vasoconstrictor Agents | 2003 |
Angiotensin II blockade restores albumin reabsorption in the proximal tubules of diabetic rats.
Topics: Albuminuria; Angiotensin II; Animals; Blood Glucose; Diabetic Nephropathies; Endocytosis; Kidney Tubules, Proximal; Low Density Lipoprotein Receptor-Related Protein-2; Male; Rats; Rats, Sprague-Dawley; Serum Albumin; Vasoconstrictor Agents | 2003 |
Role for thromboxane receptors in angiotensin-II-induced hypertension.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Cardiomegaly; Cyclooxygenase 1; Heart; Heart Rate; Hypertension; Isoenzymes; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Prostaglandin-Endoperoxide Synthases; Receptors, Thromboxane A2, Prostaglandin H2; Survival Analysis | 2004 |
[Microalbuminuria is an early marker for increased morbidity and mortality].
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Cardiovascular Diseases; Clinical Trials as Topic; Coronary Disease; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Hypertension; Losartan; Male; Meta-Analysis as Topic; Prevalence; Proteinuria; Renin-Angiotensin System; Risk Factors; Stroke | 2003 |
Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Extracellular Fluid; Kidney; Losartan; Nitric Oxide; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles; Valine; Valsartan | 2004 |
Increased renal production of angiotensin II and thromboxane B2 in conscious diabetic rats.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Experimental; Extracellular Fluid; Kidney; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles; Thromboxane B2; Valine; Valsartan | 2005 |
Complement activation in angiotensin II-induced organ damage.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Blood Pressure; C-Reactive Protein; Complement Activation; Complement C3; Complement Membrane Attack Complex; Humans; Interleukin-6; Kidney; Male; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tumor Necrosis Factor-alpha | 2005 |
Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Enalapril; Gene Expression Regulation; Kidney Cortex; Male; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Necrosis Factor-alpha | 2005 |
Prevention and reversal by enalapril of target organ damage in angiotensin II hypertension.
Topics: Acetophenones; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Models, Animal; Enalapril; Hypertension; Male; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2005 |
Prevention of hypertension and organ damage in 2-kidney, 1-clip rats by tetradecylthioacetic acid.
Topics: Albuminuria; Angiotensin II; Animals; Blood Vessels; Dinoprost; Fatty Acids; Hypertension, Renovascular; Kidney; Liver; Male; Oleic Acid; Proteinuria; Rats; Rats, Wistar; Renin; RNA, Messenger; Sulfides; Vasoconstrictor Agents | 2006 |
Sex differences in the renal changes elicited by angiotensin II blockade during the nephrogenic period.
Topics: Albuminuria; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Blood Pressure; Female; Glomerular Filtration Rate; Imidazoles; Kidney; Kidney Glomerulus; Male; Rats; Rats, Sprague-Dawley; Sex Characteristics; Tetrazoles | 2007 |
Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage.
Topics: Albuminuria; Angiotensin II; Animals; Atherosclerosis; Cells, Cultured; Endothelial Cells; Gene Expression Regulation; Humans; Hypertension; I-kappa B Proteins; Inflammation; Intercellular Adhesion Molecule-1; Kidney Diseases; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Cardiovascular; Nephritis; NF-kappa B; NF-KappaB Inhibitor alpha; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Organ Specificity; Receptor, TIE-1; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Sodium Chloride, Dietary; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2007 |
Endothelial NF-kappaB as a mediator of kidney damage: the missing link between systemic vascular and renal disease?
Topics: Albuminuria; Angiotensin II; Animals; Atherosclerosis; Endothelium, Vascular; Fibrosis; Gemfibrozil; Humans; Hypertension; I-kappa B Proteins; Inflammation; Kidney Diseases; Mice; Models, Cardiovascular; NF-kappa B; NF-KappaB Inhibitor alpha; Nitric Oxide; Nitric Oxide Synthase Type III; Organ Specificity; Sodium Chloride, Dietary | 2007 |
Sex and sex hormones influence the development of albuminuria and renal macrophage infiltration in spontaneously hypertensive rats.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Female; Gene Expression Regulation; Kidney; Macrophages; Male; Orchiectomy; Ovariectomy; Oxidative Stress; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Sex Characteristics | 2007 |
Simvastatin reverses target organ damage and oxidative stress in Angiotensin II hypertension: comparison with apocynin, tempol, and hydralazine.
Topics: Acetophenones; Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Cardiomegaly; Carotid Arteries; Cyclic N-Oxides; Hydralazine; Hypertension; Hypolipidemic Agents; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Simvastatin; Spin Labels; Superoxides; Tunica Media | 2007 |
Attenuation of NADPH oxidase activation and glomerular filtration barrier remodeling with statin treatment.
Topics: Albuminuria; Angiotensin II; Animals; Animals, Genetically Modified; Biomarkers; Blood Pressure; Cell Line, Transformed; Enzyme Activation; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Isoenzymes; Kidney Cortex; Kidney Glomerulus; Male; Mice; Microscopy, Electron; NADPH Oxidases; Oxidative Stress; Podocytes; Pyrimidines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Renin; Rosuvastatin Calcium; Sulfonamides | 2008 |
Sex differences in the pressor response to angiotensin II when the endogenous renin-angiotensin system is blocked.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Blood Pressure; Drug Interactions; Eating; Enalapril; Estradiol; Female; Kidney Cortex; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Sex Characteristics; Sodium Chloride, Dietary; Testosterone; Vasoconstrictor Agents | 2008 |
Stimulation of lymphocyte responses by angiotensin II promotes kidney injury in hypertension.
Topics: Albuminuria; Angiotensin II; Animals; Cardiomegaly; Cell Proliferation; Cytoskeleton; Disease Models, Animal; Hypertension; Immunosuppressive Agents; Interferon-gamma; Kidney Diseases; Male; Mice; Mice, Knockout; Mycophenolic Acid; Sodium Chloride, Dietary; T-Lymphocytes; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vasoconstrictor Agents | 2008 |
Role of angiotensin II-induced renal functional changes in mesangial deposition of exogenous ferritin in rats.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Ferritins; Fluorescent Antibody Technique; Inulin; Kidney; Kidney Glomerulus; Kinetics; Macromolecular Substances; Male; p-Aminohippuric Acid; Rats; Rats, Inbred Strains | 1983 |
Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats.
Topics: Albuminuria; Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Body Weight; Enalapril; Hemodynamics; Hypertension, Renovascular; Imidazoles; Kidney; Losartan; Male; Organ Size; Random Allocation; Rats; Rats, Wistar; Tetrazoles | 1995 |
Association between left ventricular hypertrophy and erythrocyte sodium-lithium exchange in normotensive subjects with and without NIDDM.
Topics: Adult; Aged; Albuminuria; Angiotensin II; Antiporters; Blood Pressure; Body Mass Index; Chi-Square Distribution; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Echocardiography, Doppler, Pulsed; Epinephrine; Erythrocytes; Female; Glycated Hemoglobin; Heart Rate; Humans; Hypertrophy, Left Ventricular; Insulin; Lithium; Male; Middle Aged; Norepinephrine; Regression Analysis; Sodium | 1995 |
The effect of acute angiotensin II blockade on renal function in rats with reduced renal mass.
Topics: Albuminuria; Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Hypertension, Renal; Imidazoles; Kidney; Losartan; Male; Natriuresis; Nephrectomy; Punctures; Rats; Rats, Wistar; Tetrazoles; Time Factors | 1994 |
Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Cerebrovascular Disorders; Extracellular Matrix; Gene Expression; Hypertension, Renal; Kidney; Kidney Glomerulus; Male; Phenotype; Prodrugs; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; RNA, Messenger; Sclerosis; Tetrazoles; Transforming Growth Factor beta | 1994 |
Dissociation of blood pressure and albuminuria in normal subjects infused with angiotensin II and noradrenaline.
Topics: Adolescent; Adult; Albuminuria; Angiotensin II; Blood Pressure; Humans; Male; Norepinephrine; Random Allocation | 1993 |
Angiotensin blockade and the progression of renal damage in the spontaneously hypertensive rat.
Topics: Albuminuria; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Chromatography, High Pressure Liquid; Hydralazine; Hypertension; Indans; Kidney; Male; Proteinuria; Rats; Rats, Inbred SHR; Survival Analysis; Tetrazoles | 1993 |
Angiotensinase A gene expression and enzyme activity in isolated glomeruli of diabetic rats.
Topics: Albuminuria; Aminopeptidases; Angiotensin II; Animals; Blood Glucose; Blotting, Northern; Body Weight; Diabetes Mellitus, Experimental; Gene Expression; Glomerular Filtration Rate; Glutamyl Aminopeptidase; Immunohistochemistry; In Vitro Techniques; Insulin; Kidney; Kidney Glomerulus; Kinetics; Male; Organ Size; Rats; Rats, Wistar; Saralasin; Time Factors | 1996 |
Inhibition of aminopeptidase A activity causes an acute albuminuria in mice: an angiotensin II-mediated effect?
Topics: Acute Disease; Albuminuria; Aminopeptidases; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Enalapril; Glutamyl Aminopeptidase; Histocytochemistry; Imidazoles; In Situ Hybridization; Losartan; Mice; Mice, Inbred BALB C; Tetrazoles | 1996 |
Subpressor doses of angiotensin II do not increase albumin excretion in humans.
Topics: Adult; Albuminuria; Angiotensin II; Antihypertensive Agents; Blood Pressure; Case-Control Studies; Exercise Test; Female; Humans; Hypertension; Male; Renal Circulation | 1996 |
Salt restriction reduces hyperfiltration, renal enlargement, and albuminuria in experimental diabetes.
Topics: Albuminuria; Angiotensin II; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, Sodium-Restricted; Glomerular Filtration Rate; Kidney; Male; Organ Size; Rats; Rats, Sprague-Dawley; Reference Values; Regression Analysis; Renin; Time Factors | 1997 |
Enhanced effects of insulin and angiotensin II on intracellular pH and free cytosolic calcium in fibroblasts from microalbuminuric patients with non-insulin-dependent diabetes mellitus.
Topics: Aged; Albuminuria; Angiotensin II; Calcium; Cell Culture Techniques; Cytosol; Diabetes Mellitus, Type 2; Female; Fibroblasts; Humans; Hydrogen-Ion Concentration; Insulin; Male; Middle Aged; Skin | 1996 |
Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathy.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Captopril; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Kidney; Nephrectomy; Pyrimidines; Rats; Rats, Wistar; Tetrazoles | 1997 |
Urinary albumin excretion rate during angiotensin II infusion in microalbuminuric patients with insulin and non-insulin-dependent diabetes mellitus.
Topics: Adult; Aged; Albuminuria; Angiotensin II; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged | 1997 |
Elevated albumin excretion in nonmodulating essential hypertensive patients.
Topics: Adult; Albuminuria; Angiotensin II; Blood Pressure; Cardiovascular Diseases; Case-Control Studies; Drug Resistance; Humans; Hypertension; Kidney; Kidney Diseases; Male; Middle Aged; Phenotype; Renin; Risk Factors; Sodium, Dietary | 1997 |
Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies.
Topics: Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Kidney; Kidney Glomerulus; Male; Organ Size; Ramipril; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 1997 |
Angiotensin blockade improves cardiac and renal complications of type II diabetic rats.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cilazapril; Coronary Vessels; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Glucose Tolerance Test; Imidazoles; Insulin; Male; Proteinuria; Pyridines; Rats; Rats, Inbred Strains | 1997 |
Bosentan prevents preglomerular alterations during angiotensin II hypertension.
Topics: Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Endothelin-1; Hypertension; Kidney Glomerulus; Male; Microscopy, Video; Rats; Rats, Sprague-Dawley; Renal Circulation; Sulfonamides; Systole | 1997 |
High-protein diets augment albuminuria in rats with Heymann nephritis by angiotensin II-dependent and -independent mechanisms.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Dietary Proteins; Enalapril; Glomerular Filtration Rate; Glomerulonephritis; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin | 1998 |
Enhanced responsiveness of blood pressure to sodium intake and to angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria.
Topics: Adrenal Glands; Adult; Albuminuria; Angiotensin II; Blood Pressure; Body Weight; Diabetes Mellitus, Type 1; Diet; Diet, Sodium-Restricted; Female; Hemodynamics; Humans; Insulin; Insulin Resistance; Male; Middle Aged; Natriuresis; Potassium; Renal Circulation; Sodium | 1998 |
Chronic bradykinin infusion and receptor blockade in angiotensin II hypertension in rats.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Disease Models, Animal; Hemodynamics; Hypertension; Kidney; Male; Organ Size; Potassium; Rats; Rats, Sprague-Dawley | 1999 |
Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Blood Pressure; Cyclosporine; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Heart Diseases; Humans; Hypertension, Renal; Interleukin-6; Kidney; Male; Monocytes; Myocardium; Neutrophils; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Protein Binding; Rats; Renin | 2000 |
Blood pressure-independent effects in rats with human renin and angiotensinogen genes.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Diuresis; Glomerular Filtration Rate; Humans; Hydralazine; Hydrochlorothiazide; Ki-67 Antigen; Kidney; Male; Myocardium; Natriuresis; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; Reserpine; Sodium; Transgenes | 2000 |
Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats.
Topics: Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Glomerulosclerosis, Focal Segmental; Imidazoles; Immunohistochemistry; In Situ Hybridization; Kidney; Male; Nephrectomy; Neural Inhibition; Norepinephrine; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Reference Values; RNA, Messenger; Sympathetic Nervous System; Transforming Growth Factor beta | 2000 |
Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Bosentan; Cardiomegaly; Fibronectins; Heart; Humans; Hydralazine; Immunohistochemistry; Inflammation; Intercellular Adhesion Molecule-1; Kidney; Macrophages; Male; NF-kappa B; Rats; Rats, Sprague-Dawley; Renin; Sulfonamides; Thromboplastin; Transcription Factor AP-1; Vascular Cell Adhesion Molecule-1 | 2000 |
Increased gene expression of components of the renin-angiotensin system in glomeruli of genetically hypertensive rats.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Blotting, Northern; Fibronectins; Gene Expression; Glomerulosclerosis, Focal Segmental; Hydralazine; Hypertension, Renal; Kidney Glomerulus; Male; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin; Renin-Angiotensin System; Ribonucleases; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2000 |
Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.
Topics: Albuminuria; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Blood Pressure; Cell Division; Cholesterol; Creatinine; Disease Models, Animal; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intercellular Adhesion Molecule-1; Kidney; Kidney Failure, Chronic; Leukocytes; Male; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Organ Size; Phosphorylation; Plasminogen Activators; Pyridines; Rats; Rats, Sprague-Dawley; Renin; Thromboplastin; Transcription Factor AP-1; Urea; Vascular Cell Adhesion Molecule-1; Vasoconstrictor Agents | 2000 |
Additive hypotensive and anti-albuminuric effects of angiotensin-converting enzyme inhibition and angiotensin receptor antagonism in diabetic spontaneously hypertensive rats.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Captopril; Drug Therapy, Combination; Gene Expression; Hypertension; Irbesartan; Kidney; Rats; Rats, Inbred SHR; Renin; RNA, Messenger; Tetrazoles; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2001 |
Plasma angiotensin II, renin activity and serum angiotensin-converting enzyme activity in non-insulin dependent diabetes mellitus patients with diabetic nephropathy.
Topics: Adult; Albuminuria; Angiotensin II; Blood Pressure; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin | 2001 |
Albuminuria in mice after injection of antibodies against aminopeptidase A: role of angiotensin II.
Topics: Albuminuria; Aminopeptidases; Angiotensin II; Angiotensinogen; Animals; Antibodies, Monoclonal; Glutamyl Aminopeptidase; Injections; Kidney; Mice; Mice, Inbred BALB C; Mice, Knockout; Microscopy, Electron | 2001 |
[Diabetic patient with hypertension takes A-I I blocker. Less likely dialysis].
Topics: Albuminuria; Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Clinical Trials as Topic; Diabetes Complications; Diabetic Nephropathies; Humans; Hypertension; Irbesartan; Risk Factors; Tetrazoles | 2002 |
The renin-angiotensin-aldosterone system is suppressed in adults with Type 1 diabetes.
Topics: Adult; Albuminuria; Aldosterone; Angiotensin II; Diabetes Mellitus, Type 1; Female; Glycated Hemoglobin; Humans; Male; Renin; Renin-Angiotensin System | 2000 |
Determinants of glomerular permselectivity: Insights derived from observations in vivo.
Topics: Albuminuria; Angiotensin II; Animals; Blood Proteins; Capillary Permeability; Dextrans; Dogs; Glomerular Filtration Rate; Humans; Kidney Glomerulus; Macromolecular Substances; Molecular Weight; Proteinuria; Rabbits; Rats; Renin; Serum Albumin; Swine | 1977 |
Effect of angiotensin on glomerular filtration of albumin.
Topics: Albumins; Albuminuria; Angiotensin II; Animals; Filtration; Kidney; Kidney Glomerulus; Rats | 1975 |
Enhanced urinary excretion of albumin in congestive heart failure: effect of ACE-inhibition.
Topics: Adult; Aged; Albuminuria; Aldosterone; Angiotensin II; Atrial Natriuretic Factor; beta 2-Microglobulin; Captopril; Female; Heart Failure; Humans; Male; Middle Aged; Reference Values; Renin | 1992 |
Increased microalbuminuria in diabetic rats is independent of angiotensin II or glomerular proteoglycan synthesis.
Topics: Albuminuria; Angiotensin II; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Histocytochemistry; Insulin; Kidney Glomerulus; Male; Polyethyleneimine; Proteoglycans; Rats; Rats, Sprague-Dawley | 1992 |
[Studies on renal dysfunction after intra-arterial hypertensive chemotherapy (CDDP, PEP) for advanced cancer of the uterine cervix--serum.urinary alpha 1-microglobulin, beta 2-microglobulin and urinary lysozyme, albumin].
Topics: Adult; Aged; Albuminuria; Alpha-Globulins; Angiotensin II; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microglobulin; Bleomycin; Blood Pressure; Carcinoma, Squamous Cell; Cisplatin; Female; Humans; Infusions, Intra-Arterial; Kidney; Middle Aged; Muramidase; Peplomycin; Uterine Cervical Neoplasms | 1990 |
Glomerular hypertrophy accelerates hypertensive glomerular injury in rats.
Topics: Albuminuria; Analysis of Variance; Angiotensin II; Animals; Blood Pressure; Glomerular Filtration Rate; Glomerulonephritis; Hypertension, Renal; Hypertrophy; Kidney Glomerulus; Male; Nephrectomy; Rats; Rats, Inbred Strains; Reference Values; Renal Circulation; Time Factors | 1991 |
Impaired response to angiotensin II in type 1 (insulin-dependent) diabetes mellitus. Role of prostaglandins and sodium-lithium countertransport activity.
Topics: Adult; Albuminuria; Angiotensin II; Antiporters; Blood Pressure; Carrier Proteins; Diabetes Mellitus, Type 1; Erythrocytes; Female; Glomerular Filtration Rate; Humans; Hypertension; Indomethacin; Male; Potassium; Prostaglandins; Reference Values; Renal Circulation; Sodium; Vascular Resistance | 1991 |
Effects of perfusion pressure and renal flow upon albumin excretion in isolated perfused kidneys.
Topics: Albuminuria; Angiotensin II; Animals; Blood Pressure; Glomerular Filtration Rate; Kidney Glomerulus; Male; Rats; Rats, Inbred Strains; Regression Analysis; Renal Circulation | 1990 |
Renal sensitivity to angiotensin II in type 1 diabetes.
Topics: Adult; Albuminuria; Angiotensin II; Blood Pressure; Diabetes Mellitus, Type 1; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Renal Circulation; Renin; Sodium; Vascular Resistance | 1990 |
The effects of acute insulin-induced hypoglycaemia on renal function in normal human subjects.
Topics: Albuminuria; Angiotensin II; Blood Glucose; Dopamine; Epinephrine; Glomerular Filtration Rate; Humans; Hypoglycemia; Insulin; Kallikreins; Kidney; Kinetics; Norepinephrine; Reference Values; Renal Circulation; Renin; Sodium | 1989 |
The role of angiotensin-II in progressive diabetic glomerulopathy in the rat.
Topics: Albuminuria; Angiotensin II; Animals; Body Weight; Diabetic Nephropathies; DNA; Dogs; Enalapril; In Vitro Techniques; Kidney; Kidney Glomerulus; Male; Nephrectomy; Organ Size; Proteins; Rats; Rats, Inbred Strains; Reference Values | 1989 |